You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Pharma
since
auto-detected in 26 stories
20 days ago
Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year
53 days ago
Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment ⊕
found
Shares of Japan's Sumitomo Pharma fell over 12% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.
4 months ago
Pharma lobbyists to EU: Cut deals with Trump ○
Advocates for European drugmakers say other countries must follow the UK to the bargaining table to stave off tariffs and remain competitive.
Pharma lobbyists to EU: Cut deals with Trump ○
Advocates for European drugmakers say other countries must follow the UK to the bargaining table to stave off tariffs and remain competitive.
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies ⊖
found
Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations
Pharma sounds alarm over EU plans to procure novel medicines ⊖
Both the branded and generic drug sectors argue joint procurement can't solve all shortages problems.
5 months ago
Eli Lilly and Merck’s blockbuster drug sales power earnings ⊕⊕
found
a story from Financial Times ✅ › Financial Times
Pharma groups boost financial outlooks as revenues from flagship medicines like Zepbound and Keytruda leap
6 months ago
Pharma shake-up: Surprise change of CEO at GSK, as AstraZeneca announces New York stock market listing – business live ○
Rolling coverage of the latest economic and financial news, as GSK has appointed a new boss after announcing the departure of Dame Emma Walmsley.
GSK’s Emma Walmsley to be replaced as chief executive
I…
Pharma lobby blasts Oct. 1 Trump tariff threat ○
The European Commission says EU industry should be protected from the latest tariff threat through the EU-U.S. trade deal.
Pharma firms pile pressure on the UK as Trump's drug pricing order looms ○
A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.